Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_assertion type Assertion NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_head.
- NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_assertion description "[A highly significant relation was observed between the presence of an abnormal karyotype and the following clinical parameters: stage III (P = 0.0001), bone marrow plasma cell infiltration greater than 30% (P = 0.0001), presence of bone lesions (P = 0.0009), and beta 2-microglobulin levels greater than 4 mg/L (P = 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_provenance.
- NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_assertion evidence source_evidence_literature NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_provenance.
- NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_assertion SIO_000772 9115968 NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_provenance.
- NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_assertion wasDerivedFrom befree-2016 NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_provenance.
- NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_assertion wasGeneratedBy ECO_0000203 NP1371219.RAqUEqUTaNFKV-vx9KxjEarLvfnZP6Ja10-BkkiPwIHmM130_provenance.